Categories list

Our billing is certified by: 

Secure shopping certificates
Special Offer!

Apcalis® Oral Jelly

Apcalis® jelly (Tadalafil) is an Ajantha Pharmaceuticals’ product used for treating erectile dysfunction in men. It is a great alternative for brand and generic Cialis offered with Mango and Orange flavours.

Apcalis Oral Jelly

$2.86

ADD TO CART!Add to Cart!

Erectalis®

Erectalis® is a brand for Tadalafil manufactured by Cipla. It is used for treating Erectile Dysfunction in men and has all the advantages of commonly known Cialis®.

Erectalis

$1.79

ADD TO CART!Add to Cart!

Tadacip®

Tadacip® manufactured by Cipla is a medication used for treating male impotence. This is an alternative for well-known Cialis brand.

Tadacip

$1.79

ADD TO CART!Add to Cart!

Tadalis® Sx

Tadalis® Sx is used to treat sexual function problems such as Impotence or Erectile Dysfunction. It is manufactured by Cipla. The main active ingredient is the same as in Cialis® - Tadalafil.

Tadalis Sx

$1.79

ADD TO CART!Add to Cart!

What is a generic pill?

Very often our web site visitors ask us about generic medications. In this section we have placed some useful information about generic pills in general and about the ones we have in our product list. Click here

Free

Sample

Pills

Get

Discount

Online

Live

Support

Click here to chat

News

Diet supplements recalled on unlabeled drug worries - Reuters

Diet supplements recalled on unlabeled drug worriesReutersTwo other supplements -- Perfect Men Dietary Supplement and Herbal Drink Acai-man Mangosteen Dietary Supplement -- contain tadalafil, used to treat male erectile dysfunction

Erectile dysfunction drug seized at LAX - Los Angeles Times

LAistErectile dysfunction drug seized at LAXLos Angeles TimesThe man claimed the powder was a Chinese herb, but when officials sent samples to a lab, they identified it as tadalafil, an active pharmaceutical ingredient in erectile dysfunction drugs

News

FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.

Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years

The forming, development and monitoring of the pharmaceutical market in USA in September 2011

In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth

Copyright © www.epharmshop.com is an affiliate marketing website. All rights reserved.